MASLD

This study tests an experimental drug called DR10624 in 110 adults with fatty liver disease who are at high risk for liver scarring. The goal is to see if the drug can safely reduce liver fat and stiffness compared to a placebo. Participants receive injections and are monitored f…

This study compares two ways to lose weight and reduce liver damage in people with cardiometabolic risks like type 2 diabetes or obesity. One group will follow a Mediterranean diet with intermittent fasting, while the other group takes a weight-loss medication (naltrexone/bupropi…

This study tests a daily supplement made from traditional Mexican foods (nopal, cacao, cricket) in 60 adults with metabolic fatty liver disease (MASLD). Participants take the supplement or a placebo for 3 months, along with dietary guidance. The goal is to see if the supplement r…

This study follows 1,689 adults with fatty liver disease (MASLD) to see if non-invasive tests like MRI and Fibroscan can accurately track disease progression and predict serious liver problems. Researchers hope these scans could replace liver biopsies in future drug studies and r…

This observational study follows 163 obese adults undergoing bariatric surgery in Bahrain. Researchers aim to create a non-invasive scoring system using blood markers and ultrasound to diagnose and monitor fatty liver disease (MASLD), potentially replacing the need for liver biop…